The Head of Clinical Development reports to the CMO and is a member of the development leadership team. This leader partners with key stakeholders to define development strategy and oversee clinical development across Intellia’s portfolio, including hereditary angioedema (HAE) and transthyretin (TTR) amyloidosis. The role leads the cross-functional Clinical Development Team and provides strategic and medical leadership for product and pipeline candidates across disease areas, aligned with corporate strategy. It calls for a physician scientist with hands-on expertise and a collaborative, player-coach leadership style to advance product candidates. Intellia is a pre-commercial gene-editing company developing potential once-and-done therapies for serious diseases. Its in vivo gene-editing therapy for HAE is pending FDA review, and its two global Phase 3 trials in TTR amyloidosis—one in cardiomyopathy and one in polyneuropathy—are underway. The Head of Clinical Development provides medical oversight of clinical trials and supports scientific, regulatory, and cross-functional development activities throughout the portfolio.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree